Pfizer to Seek FDA Emergency Authorization for 3rd Booster Shot to Strengthen Protection Against Delta Variant

Pfizer will seek emergency use authorization from the FDA for a third booster shot of its Covid-19 vaccine, specifically intended to increase the immune response to the delta variant of the virus and to combat a drop-off in antibodies approximately six months after inoculation. The highly contagious delta variant has spread rapidly and currently accounts […]